Trial intelligence / Profile preview

Optimization of octreotide duration and regimen in acute pancreatitis

ChiCTR-TRC-12002506Phase 4Completed

Sponsor
West China Hospital of Sichuan University
Start
Sep 2012
Modality
Peptides
Countries
1
01

Overview

Phase 4, open-label trial of octreotide in acute pancreatitis (AP) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: TNF-alpha, IL-6 and 2 more. Started Sep 2012; status: completed.

02

Drugs

octreotide
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on ChiCTR-TRC-12002506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call